Hussain Iqbal J

Insider·Centessa Pharmaceuticals plc·CNTA·Insider since 2025·Form 4 filings: 17
Trades YTD
2
Trades (12m)
10
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

10 transactions
02 Feb 2026
SOLD
$CNTA
38,951
$25.15
S
30 Jan 2026
SOLD
$CNTA
1,010
$25.01
S
17 Nov 2025
SOLD
$CNTA
6,000
$27.64
S
15 Oct 2025
SOLD
$CNTA
6,000
$22.41
S
15 Sep 2025
SOLD
$CNTA
6,000
$21.85
S
10 Sep 2025
SOLD
$CNTA
20,000
$22.00
S
09 Sep 2025
SOLD
$CNTA
20,000
$20.01
S
15 Aug 2025
SOLD
$CNTA
6,000
$17.23
S
15 Jul 2025
SOLD
$CNTA
6,000
$14.93
S
24 Jun 2025
SOLD
$CNTA
12,000
$14.02
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Centessa Pharmaceuticals plc

last 30 days

No active insider cluster at Centessa Pharmaceuticals plc in the last 30 days. J's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event J is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 12:17 UTC.